The levels of RBBP7, YEATS2, and ARS were significantly evaluated in the TT and PT samples compared with the NC samples (all P < 0.05), but no statistical significance was found between the PT and TT samples (all P > 0.05), indicating that ARS was possibly associated with tumor immunity of early-stage LUAD. This evidence concerns the gene YEATS2 and neoplasm.